In accordance with CMS' Open Payments transparency program, physicians and teaching hospitals that want to review data about payments they have received from drug and device manufacturers can soon begin registering to do so with the agency(www.cms.gov), which will maintain the data.
On June 1, CMS will open the registration process through which these entities can eventually access information about payments or other transfers of value they received from industry before the data are posted. The first step is to register on the CMS Enterprise Portal(portal.cms.gov). In the coming weeks, CMS will provide additional guidance on how to complete the registration process.
The Physician Payments Sunshine Act, a component of the Patient Protection and Affordable Care Act, calls for increased transparency regarding financial arrangements between medical companies and physicians. As part of the Open Payments program CMS created to implement this directive, all transfers of value to physicians who are legally able to practice will be recorded regardless of whether they participate in Medicare, Medicaid or the Children's Health Insurance Program. Medical residents are excluded from the program.
There's an App for That
As part of its Open Payments transparency program, CMS has created a mobile app for physicians(www.cms.gov) to help them track and ensure that information about payments and other transfers of value made to them by drug and device manufacturers is accurate.
The minimum threshold for reporting is $10 this year. Speaking fees for certain accredited CME activities were exempted from the reporting requirements at the request of AAFP and other groups.
Drug and medical device manufacturers were required to maintain data on all payments made to physicians beginning in August 2013. Although these manufacturers, as well as group purchasing organizations, are required to submit this information to CMS, registration by physicians and teaching hospitals is voluntary, although it is required if a physician or teaching hospital wants to be able to review and dispute the data.
The data review and publication process has been scheduled in phases. In July, physicians will be able to review the data submitted by medical companies. Data that a physician disputes but that has not been corrected by the industry will be published, but it will be designated as disputed. All data will be made publicly available beginning Sept. 30.
Related AAFP News Coverage
CMS Announces Updated Schedule for Transparency in Payments to Physicians
More From AAFP
Open Payments/Physician Sunshine Act